ACTN1 and hepatocellular carcinoma: These findings are in line with recent reports showing that depletion of ACTN1 (Chen et al, 2021; Xie et al, 2020) inhibited the growth of hepatocellular carcinoma and oral squamous cell carcinoma, however it has not yet been explored for improving sensitivity to NAC in TNBC.